Genotypic resistance tests for the management of the HIV-infected pregnant patient in Africa.

Abstract excerpt

Single witness: The current development of guidelines for antiretroviral therapy in resource-limited settings raised the issues of the possible use of drug resistance testing (DRT) in middle- and low-income countries, especially in the context of prevention of mother-to-child transmission (MTCT) programmes. Although resource limitation make it clear that DRT cannot be recommended as an essential part of clinical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Africa
• Share to Anti-HIV Agents
• Share to Antiretroviral Therapy, Highly Active